Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, advanced wound care, ophthalmology, uro-gynecology, aesthetic and regenerative medicine. Nearly 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (+1,100 patents). Manufacturing operations – located in Italy - are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in 100+ countries worldwide, as well as wholly-owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Egypt and Middle East.